The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Share News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks start second half in green amid PMIs

Mon, 03rd Jul 2023 09:07

(Alliance News) - European markets rose at Monday's open, kicking off the start of the second half on a positive note, boosted by strong trading in Asia and New York,

The FTSE 100 index opened up 18.52 points, 0.3%, at 7,550.05. The FTSE 250 was up 72.89 points, 0.4%, at 18,489.65, and the AIM All-Share was up 0.65 point, 0.1%, at 754.16.

The Cboe UK 100 was up 0.2% at 753.09, the Cboe UK 250 was up 0.3% at 16,141.46, and the Cboe Small Companies was up 0.1% at 13,727.97.

"The FTSE 100 opened marginally higher, helped by the tailwinds of a strong session in Asia and on Wall Street on Friday. But it's still struggling to find significant momentum, dragged down by concerns about growth in China and the wider global economy," commented Hargreaves Lansdown's Susannah Streeter.

In European equities, the CAC 40 in Paris was up 0.2%, while the DAX 40 in Frankfurt was up 0.3%.

Shares in Tesla were up 5.2% in Frankfurt after the US automaker said deliveries in the second quarter beat market estimates.

The electric car maker delivered 466,140 vehicles, an 83% increase year-on-year and above estimates of 450,000.

"The electric vehicle giant has benefitted from US federal credits which are designed to encourage consumers to shift away from diesel and petrol cars," interactive investor's Victoria Scholar said. "Its strategy to cut prices this year has also paid off amid the macroeconomic headwinds but could weigh on profit margins ahead."

Tesla's production is still a long way below that of major car makers such as Toyota, which produced nearly 950,000 vehicles in May alone this year.

In Asia on Monday, markets took their cue from the strong performance on Wall Street, despite some mixed economic data for the region.

The Nikkei 225 index in Tokyo closed up 1.7%, with Toyota up 0.7%.

In China, the Shanghai Composite closed up 1.3%, while the Hang Seng index in Hong Kong was up 2.3%. The S&P/ASX 200 in Sydney closed up 0.6%.

Early economic data pointed towards a slowdown in Asian manufacturing.

The Caixin purchasing managers' index for China's manufacturing indicated marginal growth in June, albeit at a slower pace than in May. Meanwhile, the au Jibun Bank PMI for Japan showed its manufacturing sector slipped back into a slight contraction. Respondents in Japan noted especially weak demand from mainland China, with exports orders continuing to fall.

In the US on Friday, Wall Street ended higher, with the Dow Jones Industrial Average up 0.8%, the S&P 500 up 1.2% and the Nasdaq Composite up 1.5%. Sentiment was lifted by a cooler-than-expected US inflation print, which boosted hopes that the Federal Reserve's rate-rising spree might be close to an end.

Still, the dollar was firm against other major currencies in early exchanges in Europe on Monday.

Sterling was quoted at USD1.2670, lower than USD1.2706 at the London equities close on Friday. The euro traded at USD1.0880, lower from USD1.0916. Against the yen, the dollar was quoted at JPY144.75, up versus JPY144.58.

In London, supermarket chain Tesco rose 0.9% as it named Gerry Murphy as its new chair from September 1.

Murphy is currently chair of luxury fashion firm Burberry and food supplier Tate & Lyle, and will step down from his role at the latter to "ensure he has sufficient capacity" for his new role at Tesco.

Murphy was also previously CEO at Kingfisher, and has held non-executive directorships at companies including British American Tobacco and Reckitt Benckiser.

Shares in Tate & Lyle fell 0.5%, while Buberry was trading flat.

Anglo American rose 2.3%, as it announced late on Friday that its diamond business, de Beers, reached an eleventh-hour deal with the Botswanan government. This followed months of tense negotiations that saw the continent's top producer threatening to cut ties with the storied diamond company.

The Botswana government and Anglo-American, have reached an "agreement in principle", the two sides said in a statement issued late Friday. The agreement provides for a new 10-year agreement to sell the rough diamonds produced by Debswana – a joint venture equally owned by the government and De Beers – and a 25-year extension of its mining licenses.

AstraZeneca fell 5.9% in early trade - the worst large-cap performer - as it announced high-level results from the Tropian-Lung01 phase III trial.

The trial looked at datopotamab deruxtecan, or Dato-DXd, in advanced non-small cell lung cancer. In patients will locally advanced or metastatic NSCLC treated with at last one prior therapy, the treatment showed a "statistically significant" improvement for the dual primary endpoint of progression-free survival compared to docetaxel, the current standard of care chemotherapy.

However, for the dual primary endpoint of overalll survival, the data "were not mature".

"An early trend was observed in favour of datopotamab deruxtecan versus docetaxel that did not meet the prespecified threshold for statistical significance at this interim analysis," AstraZeneca said.

The trial will continue as planned in order to assess OS with greater security.

On AIM, Yourgene Health more than doubled in value, with its shares reaching 0.47 pence from 0.20p on Friday.

The molecular diagnostic group has agreed a cash takeover offer with Novacyt UK, a wholly-owned subsidiary of fellow AIM listing Novacyt. The offer of 0.522p a share values the company at GBP16.7 million.

Novacyt is a biotechnology group focused on clinical diagnostics. Its shares were up 16%.

"The acquisition combines highly complementary technologies and services, with the enlarged group able to leverage mutual research and development capabilities for ongoing product development and portfolio enhancement to improve the customer offering," the companies said.

Gold was quoted at USD1,916.08 an ounce early Monday, higher than USD1,915.48 on Friday. Brent oil was trading at USD75.28 a barrel, little changed from USD75.58

There are more manufacturing PMI readings to come, including the UK at 0930 BST and the US at 1445 BST.

Financial markets in New York close at 1300 local time on Monday for Independence Day. They stay closed on Tuesday for the US public holiday.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
10 Jul 2019 10:07

Yourgene Health Swings To Profit After Debt Write-Off, Strong Trading

(Alliance News) - Yourgene Health PLC on Wednesday posted a swing to profit for its recent financial year due to improved trading and substantial gains on debt restructuring.Shares in were

Read more
3 Jun 2019 16:04

DIRECTOR DEALINGS: Yourgene Health Non-Exec Chair Reynolds Buys Shares

LONDON (Alliance News) - Yourgene Health PLC on Monday said Non-Executive Chair Adam Reynolds bought shares in the diagnostic products developer in a transaction on Friday last purchased 900,000 a

Read more
3 Jun 2019 15:26

Director dealings: Yourgene chairman raises stake

(Sharecast News) - Yourgene Health revealed on Monday that chairman Adam Reynolds had acquired 900,000 ordinary shares in the AIM-listed molecular diagnostics outfit.

Read more
9 May 2019 17:32

DIRECTOR DEALINGS: Yourgene Finance And Operating Chiefs Buy Shares

LONDON (Alliance News) - Yourgene Health PLC said on Thursday that Chief Financial Officer Barry Hextall and Chief Operating Officer Hayden Jeffreys have purchased around GBP35,800 in stock them

Read more
17 Apr 2019 17:29

Yourgene Health Fundraises To Buy Delta Diagnostics For GBP9 Million (ALLISS)

LONDON (Alliance News) - Yourgene Health PLC on Wednesday proposed an acquisition of Delta Diagnostics UK Ltd for an enterprise value of GBP8.8 million.The diagnostic products developer of

Read more
8 Apr 2019 11:37

Yourgene revenues beat estimates on solid international performance

(Sharecast News) - Molecular diagnostics group Yourgene saw annual revenues exceed market expectations in its 2018 trading year, driven by a strong performance from its international arm.

Read more
8 Apr 2019 09:13

International Performance Leads Revenue Rise For Yourgene Health

LONDON (Alliance News) - Yourgene Health PLC on Monday said its annual revenue was ahead of market expectations, with international revenue particularly strong.Shares in molecular company a

Read more
8 Jan 2019 14:22

Yourgene Health launches Sage 32 plex test

(Sharecast News) - Molecular diagnostics group Yourgene Health announced the launch of the 'Sage 32' plex test - a high throughput non-invasive prenatal testing (NIPT) and analysis solution for clinical laboratories - on Tuesday.

Read more
8 Jan 2019 10:07

Yourgene Health Launches Sage 32 Plex Test For Clinical Laboratories

LONDON (Alliance News) - Yourgene Health PLC on Tuesday said it launched the Sage 32 plex test, a new high-throughput, non-invasive prenatal testing and analysis solution for clinical molecular 32

Read more
3 Dec 2018 12:01

Yourgene Health Interim Loss Narrows On Double-Digit Revenue Growth

LONDON (Alliance News) - Yourgene Health PLC on Monday said its loss narrowed in the first half of its current financial year as revenue rose on improved non-invasive prenatal testing products its

Read more
3 Dec 2018 10:27

Yourgene Health international expansion sees revenue jump 45%

(Sharecast News) - Yourgene Health's shares dropped on Monday as the company returned a loss even after interim revenue increased by almost 50%.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.